Pathological and molecular mechanisms of prostate carcinogenesis: Implications for diagnosis, detection, prevention, and treatment
10.1002/jcb.10747
Crossref journal-article
Wiley
Journal of Cellular Biochemistry (311)
Abstract

AbstractProstate cancer is an increasing threat throughout the world. As a result of a demographic shift in population, the number of men at risk for developing prostate cancer is growing rapidly. For 2002, an estimated 189,000 prostate cancer cases were diagnosed in the U.S., accompanied by an estimated 30,200 prostate cancer deaths [Jemal et al., 2002]. Most prostate cancer is now diagnosed in men who were biopsied as a result of an elevated serum PSA (>4 ng/ml) level detected following routine screening. Autopsy studies [Breslow et al., 1977; Yatani et al., 1982; Sakr et al., 1993], and the recent results of the Prostate Cancer Prevention Trial (PCPT) [Thompson et al., 2003], a large scale clinical trial where all men entered the trial without an elevated PSA (<3 ng/ml) were subsequently biopsied, indicate the prevalence of histologic prostate cancer is much higher than anticipated by PSA screening. Environmental factors, such as diet and lifestyle, have long been recognized contributors to the development of prostate cancer. Recent studies of the molecular alterations in prostate cancer cells have begun to provide clues as to how prostate cancer may arise and progress. For example, while inflammation in the prostate has been suggested previously as a contributor to prostate cancer development [Gardner and Bennett, 1992; Platz, 1998; De Marzo et al., 1999; Nelson et al., 2003], research regarding the genetic and pathological aspects of prostate inflammation has only recently begun to receive attention. Here, we review the subject of inflammation and prostate cancer as part of a “chronic epithelial injury” hypothesis of prostate carcinogenesis, and the somatic genome and phenotypic changes characteristic of prostate cancer cells. We also present the implications of these changes for prostate cancer diagnosis, detection, prevention, and treatment. © 2003 Wiley‐Liss, Inc.

Bibliography

De Marzo, A. M., DeWeese, T. L., Platz, E. A., Meeker, A. K., Nakayama, M., Epstein, J. I., Isaacs, W. B., & Nelson, W. G. (2003). Pathological and molecular mechanisms of prostate carcinogenesis: Implications for diagnosis, detection, prevention, and treatment. Journal of Cellular Biochemistry, 91(3), 459–477. Portico.

Authors 8
  1. Angelo M. De Marzo (first)
  2. Theodore L. DeWeese (additional)
  3. Elizabeth A. Platz (additional)
  4. Alan K. Meeker (additional)
  5. Masashi Nakayama (additional)
  6. Jonathan I. Epstein (additional)
  7. William B. Isaacs (additional)
  8. William G. Nelson (additional)
References 243 Referenced 134
  1. {'key': 'e_1_2_6_2_1', 'first-page': '3886', 'article-title': 'Nkx3.1; Pten mutant mice develop invasive prostate adenocarcinoma and lymph node metastases', 'volume': '63', 'author': 'Abate‐Shen C', 'year': '2003', 'journal-title': 'Cancer Res'} / Cancer Res / Nkx3.1; Pten mutant mice develop invasive prostate adenocarcinoma and lymph node metastases by Abate‐Shen C (2003)
  2. 10.1128/MCB.22.5.1495-1503.2002
  3. {'key': 'e_1_2_6_4_1', 'first-page': '6134', 'article-title': 'Dysregulated expression of androgen‐responsive and nonresponsive genes in the androgen‐independent prostate cancer xenograft model CWR22‐R1', 'volume': '60', 'author': 'Amler LC', 'year': '2000', 'journal-title': 'Cancer Res'} / Cancer Res / Dysregulated expression of androgen‐responsive and nonresponsive genes in the androgen‐independent prostate cancer xenograft model CWR22‐R1 by Amler LC (2000)
  4. 10.1097/00000478-199908000-00011
  5. 10.1038/35020592
  6. 10.1097/00000478-200212000-00006
  7. 10.1101/gad.13.8.966
  8. 10.1074/jbc.271.50.31779
  9. {'key': 'e_1_2_6_10_1', 'first-page': '47', 'article-title': 'Prostatic atrophy: An autopsy study of a histologic mimic of adenocarcinoma', 'volume': '11', 'author': 'Billis A', 'year': '1998', 'journal-title': 'Mod Pathol'} / Mod Pathol / Prostatic atrophy: An autopsy study of a histologic mimic of adenocarcinoma by Billis A (1998)
  10. 10.5858/2003-127-840-IAOTP / Arch Pathol Lab Med / Inflammatory atrophy of the prostate. Prevalence and significance by Billis A (2003)
  11. 10.1016/S0092-8674(01)80006-4
  12. {'key': 'e_1_2_6_13_1', 'first-page': '61', 'volume-title': 'Prostate cancer: Biology, genetics, and the new theraputics', 'author': 'Bookstein R', 'year': '2001'} / Prostate cancer: Biology, genetics, and the new theraputics by Bookstein R (2001)
  13. 10.1002/(SICI)1097-0142(19960715)78:2<330::AID-CNCR22>3.0.CO;2-W
  14. 10.1097/00000478-199505000-00002
  15. 10.1002/1097-0142(19920701)70:1 <291::AID-CNCR2820701317>3.0.CO;2-4
  16. {'key': 'e_1_2_6_17_1', 'first-page': '6111', 'article-title': 'Loss of NKX3.1 expression in human prostate cancers correlates with tumor progression [in process citation]', 'volume': '60', 'author': 'Bowen C', 'year': '2000', 'journal-title': 'Cancer Res'} / Cancer Res / Loss of NKX3.1 expression in human prostate cancers correlates with tumor progression [in process citation] by Bowen C (2000)
  17. {'key': 'e_1_2_6_18_1', 'first-page': '3663', 'article-title': 'Keratin immunoreactivity in the benign and neoplastic human prostate', 'volume': '45', 'author': 'Brawer MK', 'year': '1985', 'journal-title': 'Cancer Res'} / Cancer Res / Keratin immunoreactivity in the benign and neoplastic human prostate by Brawer MK (1985)
  18. 10.1002/ijc.2910200506
  19. {'key': 'e_1_2_6_20_1', 'first-page': '531', 'article-title': 'CG island methylation changes near the GSTP1 gene in prostatic intraepithelial neoplasia', 'volume': '7', 'author': 'Brooks JD', 'year': '1998', 'journal-title': 'Cancer Epidemiol Biomarkers Prev'} / Cancer Epidemiol Biomarkers Prev / CG island methylation changes near the GSTP1 gene in prostatic intraepithelial neoplasia by Brooks JD (1998)
  20. 10.1016/S0962-8924(99)01661-X
  21. {'key': 'e_1_2_6_22_1', 'first-page': '4997', 'article-title': 'Frequent inactivation of PTEN/MMAC1 in primary prostate cancer', 'volume': '57', 'author': 'Cairns P', 'year': '1997', 'journal-title': 'Cancer Res'} / Cancer Res / Frequent inactivation of PTEN/MMAC1 in primary prostate cancer by Cairns P (1997)
  22. 10.1038/ng823
  23. {'key': 'e_1_2_6_24_1', 'first-page': '324', 'article-title': 'Expression of p27kip1 in prostatic adenocarcinoma', 'volume': '11', 'author': 'Cheville JC', 'year': '1998', 'journal-title': 'Mod Pathol'} / Mod Pathol / Expression of p27kip1 in prostatic adenocarcinoma by Cheville JC (1998)
  24. {'key': 'e_1_2_6_25_1', 'volume-title': 'Prostate cancer: Biology, genetics, and the new therapeutics', 'author': 'Chung LWK', 'year': '2001'} / Prostate cancer: Biology, genetics, and the new therapeutics by Chung LWK (2001)
  25. 10.1001/jama.1996.03540240035027
  26. 10.1046/j.1464-410x.1998.00630.x
  27. 10.1093/jnci/92.1.61
  28. 10.1093/jnci/90.17.1284
  29. 10.1002/j.1460-2075.1992.tb05245.x
  30. 10.1038/nature01322
  31. 10.1038/6495
  32. 10.1210/me.7.12.1541
  33. {'key': 'e_1_2_6_34_1', 'first-page': '265', 'volume-title': 'Telomeres', 'author': 'de Lange T', 'year': '1995'} / Telomeres by de Lange T (1995)
  34. 10.1016/S0002-9440(10)65632-5
  35. 10.1016/S0022-5347(01)62196-7
  36. 10.1016/S0002-9440(10)65517-4
  37. 10.1016/S0140-6736(03)12779-1
  38. 10.1097/00001648-200201000-00012
  39. 10.1016/S0090-4295(02)01637-0
  40. 10.1038/35090585
  41. 10.1038/84879
  42. 10.1016/S0022-5347(05)68239-0
  43. 10.1038/sj.cgt.7700416
  44. 10.1038/34923
  45. {'key': 'e_1_2_6_46_1', 'first-page': '2959', 'article-title': 'Allelic loss on chromosome 8p12‐21 in microdissected prostatic intraepithelial neoplasia', 'volume': '55', 'author': 'Emmert‐Buck MR', 'year': '1995', 'journal-title': 'Cancer Res'} / Cancer Res / Allelic loss on chromosome 8p12‐21 in microdissected prostatic intraepithelial neoplasia by Emmert‐Buck MR (1995)
  46. {'key': 'e_1_2_6_47_1', 'volume-title': 'Prostate biopsy interpretation', 'author': 'Epstein JI', 'year': '1995'} / Prostate biopsy interpretation by Epstein JI (1995)
  47. 10.1016/S0022-5347(05)65953-8
  48. 10.1097/00000478-199607000-00008
  49. {'key': 'e_1_2_6_50_1', 'first-page': '4515', 'article-title': 'Inactivation of glutathione S‐transferase P1 gene by promoter hypermethylation in human neoplasia', 'volume': '58', 'author': 'Esteller M', 'year': '1998', 'journal-title': 'Cancer Res'} / Cancer Res / Inactivation of glutathione S‐transferase P1 gene by promoter hypermethylation in human neoplasia by Esteller M (1998)
  50. 10.1002/(SICI)1097-0045(199603)28:3<162::AID-PROS3>3.0.CO;2-H
  51. 10.1038/35094009
  52. 10.1038/nrc1142
  53. 10.1136/jcp.49.9.741
  54. 10.1038/72861
  55. 10.1002/(SICI)1096-9896(199904)187:5<563::AID-PATH292>3.0.CO;2-3
  56. 10.1002/path.1700680234
  57. {'key': 'e_1_2_6_58_1', 'first-page': '5002', 'article-title': 'The phosphoinositol phosphatase activity of PTEN mediates a serum‐sensitive G1 growth arrest in glioma cells', 'volume': '58', 'author': 'Furnari FB', 'year': '1998', 'journal-title': 'Cancer Res'} / Cancer Res / The phosphoinositol phosphatase activity of PTEN mediates a serum‐sensitive G1 growth arrest in glioma cells by Furnari FB (1998)
  58. {'key': 'e_1_2_6_59_1', 'first-page': '2861', 'article-title': 'Frequent detection of codon 877 mutation in the androgen receptor gene in advanced prostate cancers', 'volume': '54', 'author': 'Gaddipati JP', 'year': '1994', 'journal-title': 'Cancer Res'} / Cancer Res / Frequent detection of codon 877 mutation in the androgen receptor gene in advanced prostate cancers by Gaddipati JP (1994)
  59. {'key': 'e_1_2_6_60_1', 'first-page': '1225', 'article-title': 'Lower prostate cancer risk in men with elevated plasma lycopene levels: Results of a prospective analysis', 'volume': '59', 'author': 'Gann PH', 'year': '1999', 'journal-title': 'Cancer Res'} / Cancer Res / Lower prostate cancer risk in men with elevated plasma lycopene levels: Results of a prospective analysis by Gann PH (1999)
  60. 10.1007/978-1-59259-125-1_16
  61. {'key': 'e_1_2_6_62_1', 'first-page': '129', 'volume-title': 'Pathology and pathobiology of the urinary bladder and prostate', 'author': 'Gardner WA', 'year': '1992'} / Pathology and pathobiology of the urinary bladder and prostate by Gardner WA (1992)
  62. 10.1016/S0022-5347(05)65140-3
  63. 10.1074/jbc.M204131200
  64. 10.1093/oxfordjournals.epirev.a000783
  65. 10.1016/S0022-5347(17)36457-1
  66. {'key': 'e_1_2_6_67_1', 'first-page': '2105', 'article-title': 'p27Kip1 is required for PTEN‐induced G1 growth arrest', 'volume': '61', 'author': 'Gottschalk AR', 'year': '2001', 'journal-title': 'Cancer Res'} / Cancer Res / p27Kip1 is required for PTEN‐induced G1 growth arrest by Gottschalk AR (2001)
  67. 10.1074/jbc.M003145200
  68. 10.1038/bjc.1998.674
  69. 10.1159/000474171 / Eur Urol / Atypical adenomatous hyperplasia of the prostate: A critical review by Grignon DJ (1996)
  70. 10.1093/carcin/14.11.2313
  71. 10.1093/oxfordjournals.epirev.a000782
  72. {'key': 'e_1_2_6_73_1', 'first-page': '2269', 'article-title': 'Loss of the cyclin‐dependent kinase inhibitor P27(Kip1) protein in human prostate cancer correlates with tumor grade', 'volume': '3', 'author': 'Guo YP', 'year': '1997', 'journal-title': 'Clin Cancer Res'} / Clin Cancer Res / Loss of the cyclin‐dependent kinase inhibitor P27(Kip1) protein in human prostate cancer correlates with tumor grade by Guo YP (1997)
  73. 10.1038/labinvest.3780378
  74. 10.1023/A:1015788502099
  75. 10.1038/sj.onc.1205061
  76. {'key': 'e_1_2_6_77_1', 'first-page': '43', 'article-title': 'Studies of Japanese migrants. I. Mortality from cancer and other diseases among Japanese in the United States', 'volume': '40', 'author': 'Haenszel W', 'year': '1968', 'journal-title': 'J Natl Cancer Inst'} / J Natl Cancer Inst / Studies of Japanese migrants. I. Mortality from cancer and other diseases among Japanese in the United States by Haenszel W (1968)
  77. 10.1038/345458a0
  78. 10.1002/pros.2990250206
  79. 10.1054/bjoc.1999.0986
  80. 10.1006/geno.1997.4715
  81. 10.1097/00000478-198905000-00006
  82. 10.1093/jnci/90.6.440 / J Natl Cancer Inst / Prostate cancer and supplementation with alpha‐tocopherol and beta‐carotene: Incidence and mortality in a controlled trial [see comments] by Heinonen OP (1998)
  83. 10.1073/pnas.95.9.5275
  84. {'key': 'e_1_2_6_85_1', 'first-page': '4640', 'article-title': 'Interleukin‐6 regulates prostate‐specific protein expression in prostate carcinoma cells by activation of the androgen receptor', 'volume': '58', 'author': 'Hobisch A', 'year': '1998', 'journal-title': 'Cancer Res'} / Cancer Res / Interleukin‐6 regulates prostate‐specific protein expression in prostate carcinoma cells by activation of the androgen receptor by Hobisch A (1998)
  85. 10.1002/(SICI)1097-0215(20000101)85:1<60::AID-IJC11>3.0.CO;2-B
  86. 10.1006/geno.1999.5822
  87. 10.1016/S0022-5347(01)64957-7
  88. {'key': 'e_1_2_6_89_1', 'first-page': '514', 'article-title': 'Molecular biology of prostate cancer', 'volume': '21', 'author': 'Isaacs WB', 'year': '1994', 'journal-title': 'Semin Oncol'} / Semin Oncol / Molecular biology of prostate cancer by Isaacs WB (1994)
  89. {'key': 'e_1_2_6_90_1', 'first-page': '257', 'article-title': "Oltipraz chemoprevention trial in Qidong, People's Republic of China: Study design and clinical outcomes", 'volume': '6', 'author': 'Jacobson LP', 'year': '1997', 'journal-title': 'Cancer Epidemiol Biomarkers Prev'} / Cancer Epidemiol Biomarkers Prev / Oltipraz chemoprevention trial in Qidong, People's Republic of China: Study design and clinical outcomes by Jacobson LP (1997)
  90. 10.1016/S1535-6108(02)00093-4
  91. 10.3322/canjclin.52.1.23
  92. 10.1097/00000478-200111000-00007
  93. 10.1097/00000478-200209000-00007
  94. {'issue': '105', 'key': 'e_1_2_6_95_1', 'first-page': '965', 'article-title': 'Chemoprevention by inducers of carcinogen detoxication enzymes', 'volume': '4', 'author': 'Kensler TW', 'year': '1997', 'journal-title': 'Environ Health Perspect'} / Environ Health Perspect / Chemoprevention by inducers of carcinogen detoxication enzymes by Kensler TW (1997)
  95. {'key': 'e_1_2_6_96_1', 'first-page': '127', 'article-title': "Oltipraz chemoprevention trial in Qidong, People's Republic of China: Modulation of serum aflatoxin albumin adduct biomarkers", 'volume': '7', 'author': 'Kensler TW', 'year': '1998', 'journal-title': 'Cancer Epidemiol Biomarkers Prev'} / Cancer Epidemiol Biomarkers Prev / Oltipraz chemoprevention trial in Qidong, People's Republic of China: Modulation of serum aflatoxin albumin adduct biomarkers by Kensler TW (1998)
  96. 10.1016/S0022-5347(05)67493-9
  97. 10.1073/pnas.042688999
  98. 10.1038/386761a0
  99. 10.1016/S0027-5107(97)00035-3
  100. {'key': 'e_1_2_6_101_1', 'first-page': '314', 'article-title': 'Androgen receptor gene amplification: A possible molecular mechanism for androgen deprivation therapy failure in prostate cancer', 'volume': '57', 'author': 'Koivisto P', 'year': '1997', 'journal-title': 'Cancer Res'} / Cancer Res / Androgen receptor gene amplification: A possible molecular mechanism for androgen deprivation therapy failure in prostate cancer by Koivisto P (1997)
  101. 10.1093/oxfordjournals.epirev.a000798
  102. 10.1001/jama.282.3.236
  103. 10.1053/hupa.2003.42
  104. 10.1073/pnas.91.24.11733
  105. {'key': 'e_1_2_6_106_1', 'first-page': '1108', 'article-title': 'Aspirin use in relation to risk of prostate cancer', 'volume': '11', 'author': 'Leitzmann MF', 'year': '2002', 'journal-title': 'Cancer Epidemiol Biomarkers Prev'} / Cancer Epidemiol Biomarkers Prev / Aspirin use in relation to risk of prostate cancer by Leitzmann MF (2002)
  106. 10.1016/0022-2836(92)90096-3
  107. 10.1073/pnas.95.26.15406
  108. 10.1126/science.275.5308.1943
  109. 10.1111/j.1699-0463.1968.tb04602.x
  110. 10.1126/science.145.3627.53
  111. 10.1016/S0002-9440(10)63028-3
  112. {'key': 'e_1_2_6_113_1', 'first-page': '4683', 'article-title': 'Human prostate cancer and benign prostatic hyperplasia: Molecular dissection by gene expression profiling', 'volume': '61', 'author': 'Luo J', 'year': '2001', 'journal-title': 'Cancer Res'} / Cancer Res / Human prostate cancer and benign prostatic hyperplasia: Molecular dissection by gene expression profiling by Luo J (2001)
  113. {'key': 'e_1_2_6_114_1', 'first-page': '2220', 'article-title': 'Alpha‐methylacyl‐CoA racemase: A new molecular marker for prostate cancer', 'volume': '62', 'author': 'Luo J', 'year': '2002', 'journal-title': 'Cancer Res'} / Cancer Res / Alpha‐methylacyl‐CoA racemase: A new molecular marker for prostate cancer by Luo J (2002)
  114. 10.1016/S0090-4295(00)00468-4
  115. {'key': 'e_1_2_6_116_1', 'first-page': '5692', 'article-title': 'Expression profiling reveals hepsin overexpression in prostate cancer', 'volume': '61', 'author': 'Magee JA', 'year': '2001', 'journal-title': 'Cancer Res'} / Cancer Res / Expression profiling reveals hepsin overexpression in prostate cancer by Magee JA (2001)
  116. 10.1097/00000478-200308000-00010
  117. {'key': 'e_1_2_6_118_1', 'first-page': '944', 'article-title': 'Androgen receptor mutations in prostate cancer', 'volume': '60', 'author': 'Marcelli M', 'year': '2000', 'journal-title': 'Cancer Res'} / Cancer Res / Androgen receptor mutations in prostate cancer by Marcelli M (2000)
  118. 10.1093/genetics/26.2.234
  119. {'key': 'e_1_2_6_120_1', 'first-page': '4291', 'article-title': 'Loss of PTEN expression in paraffin‐embedded primary prostate cancer correlates with high Gleason score and advanced stage', 'volume': '59', 'author': 'McMenamin ME', 'year': '1999', 'journal-title': 'Cancer Res'} / Cancer Res / Loss of PTEN expression in paraffin‐embedded primary prostate cancer correlates with high Gleason score and advanced stage by McMenamin ME (1999)
  120. 10.1002/1097-0142(196901)23:1<24::AID-CNCR2820230103>3.0.CO;2-1
  121. {'key': 'e_1_2_6_122_1', 'first-page': '193', 'volume-title': 'Urology in the elderly', 'author': 'McNeal JE', 'year': '1984'} / Urology in the elderly by McNeal JE (1984)
  122. 10.1097/00000478-198808000-00003
  123. {'key': 'e_1_2_6_124_1', 'first-page': '997', 'volume-title': 'Histology for pathologists', 'author': 'McNeal JE', 'year': '1997'} / Histology for pathologists by McNeal JE (1997)
  124. 10.1016/S0046-8177(86)80156-3
  125. {'key': 'e_1_2_6_126_1', 'first-page': '6405', 'article-title': 'Telomere shortening is an early somatic DNA alteration in human prostate tumorigenesis', 'volume': '62', 'author': 'Meeker AK', 'year': '2002', 'journal-title': 'Cancer Res'} / Cancer Res / Telomere shortening is an early somatic DNA alteration in human prostate tumorigenesis by Meeker AK (2002)
  126. {'key': 'e_1_2_6_127_1', 'volume-title': 'Prostate cancer', 'author': 'Meng MV', 'year': '2002'} / Prostate cancer by Meng MV (2002)
  127. 10.1023/A:1011256201044
  128. 10.1038/sj.onc.1202415
  129. {'key': 'e_1_2_6_130_1', 'first-page': '18', 'volume-title': 'Advanced therapy of prostate disease', 'author': 'Miller GJ', 'year': '1999'} / Advanced therapy of prostate disease by Miller GJ (1999)
  130. {'key': 'e_1_2_6_131_1', 'first-page': '92', 'article-title': 'Heterogeneity in intratumor distribution of p53 mutations in human prostate cancer', 'volume': '147', 'author': 'Mirchandani D', 'year': '1995', 'journal-title': 'Am J Pathol'} / Am J Pathol / Heterogeneity in intratumor distribution of p53 mutations in human prostate cancer by Mirchandani D (1995)
  131. 10.1111/j.1749-6632.2002.tb04108.x
  132. {'key': 'e_1_2_6_133_1', 'first-page': '599', 'article-title': 'The evolution and involution of the prostate gland', 'volume': '12', 'author': 'Moore RA', 'year': '1936', 'journal-title': 'Am J Pathol'} / Am J Pathol / The evolution and involution of the prostate gland by Moore RA (1936)
  133. 10.1093/carcin/16.4.713
  134. 10.1038/sj.onc.1204889
  135. 10.1073/pnas.94.17.9052
  136. 10.1073/pnas.95.23.13513
  137. 10.1128/MCB.20.23.8969-8982.2000
  138. 10.1016/S0002-9440(10)63452-9
  139. 10.1023/A:1022431101158
  140. 10.1074/jbc.271.33.19900
  141. {'key': 'e_1_2_6_142_1', 'first-page': '169', 'article-title': 'Inverse association of prostate cancer and non‐steroidal anti‐inflammatory drugs (NSAIDs): Results of a case–control study', 'volume': '7', 'author': 'Nelson JE', 'year': '2000', 'journal-title': 'Oncol Rep'} / Oncol Rep / Inverse association of prostate cancer and non‐steroidal anti‐inflammatory drugs (NSAIDs): Results of a case–control study by Nelson JE (2000)
  142. 10.1002/(SICI)1522-2683(20000501)21:9<1823::AID-ELPS1823>3.0.CO;2-3
  143. {'key': 'e_1_2_6_144_1', 'first-page': '103', 'article-title': 'Protection against 2‐hydroxyamino‐1‐methyl‐6‐phenylimidazo[4,5‐b]pyridine cytotoxicity and DNA adduct formation in human prostate by glutathione S‐transferase P1', 'volume': '61', 'author': 'Nelson CP', 'year': '2001', 'journal-title': 'Cancer Res'} / Cancer Res / Protection against 2‐hydroxyamino‐1‐methyl‐6‐phenylimidazo[4,5‐b]pyridine cytotoxicity and DNA adduct formation in human prostate by glutathione S‐transferase P1 by Nelson CP (2001)
  144. 10.1016/S0090-4295(00)00939-0
  145. 10.1056/NEJMra021562
  146. 10.1073/pnas.171076798
  147. 10.1073/pnas.89.14.6319
  148. {'key': 'e_1_2_6_149_1', 'first-page': '1', 'article-title': 'Prostatic inflammation in benign prostatic hyperplasia—The third component?', 'volume': '1', 'author': 'Nickel JC', 'year': '1994', 'journal-title': 'Can J Urol'} / Can J Urol / Prostatic inflammation in benign prostatic hyperplasia—The third component? by Nickel JC (1994)
  149. 10.1046/j.1464-410x.1999.00352.x
  150. 10.1002/(SICI)1097-0215(19980812)77:4<511::AID-IJC6>3.0.CO;2-X
  151. 10.1093/jnci/91.23.2038
  152. {'key': 'e_1_2_6_153_1', 'first-page': '314', 'article-title': 'Treatment and prevention of intraepithelial neoplasia: An important target for accelerated new agent development', 'volume': '8', 'author': "O'Shaughnessy JA", 'year': '2002', 'journal-title': 'Clin Cancer Res'} / Clin Cancer Res / Treatment and prevention of intraepithelial neoplasia: An important target for accelerated new agent development by O'Shaughnessy JA (2002)
  153. 10.1016/S0022-5347(01)69894-X
  154. 10.1016/S0090-4295(01)01311-5
  155. 10.1002/pros.1115
  156. 10.1172/JCI200113903
  157. {'key': 'e_1_2_6_158_1', 'first-page': '71', 'article-title': 'Prostatitis and prostate cancer', 'volume': '3', 'author': 'Platz EA', 'year': '1998', 'journal-title': 'New Developments in Prostate Cancer Treatment'} / New Developments in Prostate Cancer Treatment / Prostatitis and prostate cancer by Platz EA (1998)
  158. 10.1073/pnas.96.4.1563
  159. 10.1073/pnas.171060098
  160. 10.1002/(SICI)1097-0045(19980401)35:1<71::AID-PROS10>3.0.CO;2-H
  161. 10.1016/S0090-4295(00)00776-7
  162. {'key': 'e_1_2_6_163_1', 'first-page': '5408', 'article-title': 'Chromosomal anomalies in prostatic intraepithelial neoplasia and carcinoma detected by fluorescence in situ hybridization', 'volume': '55', 'author': 'Qian J', 'year': '1995', 'journal-title': 'Cancer Res'} / Cancer Res / Chromosomal anomalies in prostatic intraepithelial neoplasia and carcinoma detected by fluorescence in situ hybridization by Qian J (1995)
  163. 10.1073/pnas.96.5.2110
  164. 10.1073/pnas.051618798
  165. 10.1002/pros.2990020304
  166. 10.1016/S0022-5347(17)72260-4 / J Urol / On the frequency of occurrenec of occult carcinoma of the prostate by Rich AR (1934)
  167. 10.1016/S0090-4295(98)00034-X
  168. 10.4065/77.3.219
  169. 10.1001/jama.287.13.1662
  170. 10.1002/(SICI)1096-9896(199907)188:3<271::AID-PATH359>3.0.CO;2-K
  171. 10.1097/00000478-199809000-00005
  172. {'key': 'e_1_2_6_173_1', 'first-page': '5825', 'article-title': 'Ligand‐independent activation of the androgen receptor by the differentiation agent butyrate in human prostate cancer cells', 'volume': '60', 'author': 'Sadar MD', 'year': '2000', 'journal-title': 'Cancer Res'} / Cancer Res / Ligand‐independent activation of the androgen receptor by the differentiation agent butyrate in human prostate cancer cells by Sadar MD (2000)
  173. 10.1016/S0022-5347(17)35487-3
  174. {'key': 'e_1_2_6_175_1', 'first-page': '439', 'article-title': 'High grade prostatic intraepithelial neoplasia (HGPIN) and prostatic adenocarcinoma between the ages of 20–69: An autopsy study of 249 cases', 'volume': '8', 'author': 'Sakr WA', 'year': '1994', 'journal-title': 'In Vivo'} / In Vivo / High grade prostatic intraepithelial neoplasia (HGPIN) and prostatic adenocarcinoma between the ages of 20–69: An autopsy study of 249 cases by Sakr WA (1994)
  175. 10.1159/000020161
  176. 10.1111/j.1432-1033.1995.0815d.x
  177. 10.1006/bbrc.1994.1011
  178. 10.1002/(SICI)1097-0177(199705)209:1<127::AID-AJA12>3.0.CO;2-Z
  179. 10.1016/S0002-9440(10)64132-6
  180. 10.1097/00000478-200209000-00006
  181. {'key': 'e_1_2_6_182_1', 'first-page': '818', 'article-title': 'Evidence that genetic instability occurs at an early stage of colorectal tumorigenesis', 'volume': '61', 'author': 'Shih IM', 'year': '2001', 'journal-title': 'Cancer Res'} / Cancer Res / Evidence that genetic instability occurs at an early stage of colorectal tumorigenesis by Shih IM (2001)
  182. 10.1038/bjc.1991.210
  183. {'key': 'e_1_2_6_184_1', 'first-page': '195', 'article-title': 'The prostate: A target for carcinogenicity of 2‐amino‐1‐methyl‐6‐phenylimidazo[4,5‐b]pyridine (PhIP) derived from cooked foods', 'volume': '57', 'author': 'Shirai T', 'year': '1997', 'journal-title': 'Cancer Res'} / Cancer Res / The prostate: A target for carcinogenicity of 2‐amino‐1‐methyl‐6‐phenylimidazo[4,5‐b]pyridine (PhIP) derived from cooked foods by Shirai T (1997)
  184. 10.1016/S0002-9440(10)64814-6
  185. {'key': 'e_1_2_6_186_1', 'first-page': '986', 'article-title': '17‐Allylamino‐17‐demethoxygeldanamycin induces the degradation of androgen receptor and HER‐2/neu and inhibits the growth of prostate cancer xenografts', 'volume': '8', 'author': 'Solit DB', 'year': '2002', 'journal-title': 'Clin Cancer Res'} / Clin Cancer Res / 17‐Allylamino‐17‐demethoxygeldanamycin induces the degradation of androgen receptor and HER‐2/neu and inhibits the growth of prostate cancer xenografts by Solit DB (2002)
  186. {'key': 'e_1_2_6_187_1', 'first-page': '218', 'article-title': 'Telomerase activity: A prevalent marker of malignant human prostate tissue', 'volume': '56', 'author': 'Sommerfeld HJ', 'year': '1996', 'journal-title': 'Cancer Res'} / Cancer Res / Telomerase activity: A prevalent marker of malignant human prostate tissue by Sommerfeld HJ (1996)
  187. 10.1016/S0022-5347(05)65528-0
  188. 10.1073/pnas.191235898
  189. 10.1038/ng0497-356
  190. 10.1093/oxfordjournals.epirev.a000781
  191. {'key': 'e_1_2_6_192_1', 'first-page': '266', 'article-title': 'Prostate mutations in rats induced by the suspected human carcinogen 2‐amino‐1‐methyl‐6‐phenylimidazo[4,5‐b]pyridine', 'volume': '60', 'author': 'Stuart GR', 'year': '2000', 'journal-title': 'Cancer Res'} / Cancer Res / Prostate mutations in rats induced by the suspected human carcinogen 2‐amino‐1‐methyl‐6‐phenylimidazo[4,5‐b]pyridine by Stuart GR (2000)
  192. 10.1073/pnas.96.11.6199
  193. 10.1016/0960-0760(93)90316-O
  194. 10.1002/1097-0045(199609)29:3<153::AID-PROS2990290303>3.0.CO;2-5
  195. {'key': 'e_1_2_6_196_1', 'first-page': '204', 'article-title': 'Interfocal heterogeneity of PTEN/MMAC1 gene alterations in multiple metastatic prostate cancer tissues', 'volume': '58', 'author': 'Suzuki H', 'year': '1998', 'journal-title': 'Cancer Res'} / Cancer Res / Interfocal heterogeneity of PTEN/MMAC1 gene alterations in multiple metastatic prostate cancer tissues by Suzuki H (1998)
  196. 10.1210/mend.11.4.9906
  197. 10.1056/NEJM199505253322101
  198. {'key': 'e_1_2_6_199_1', 'first-page': '2511', 'article-title': 'Selection for androgen receptor mutations in prostate cancers treated with androgen antagonist', 'volume': '59', 'author': 'Taplin ME', 'year': '1999', 'journal-title': 'Cancer Res'} / Cancer Res / Selection for androgen receptor mutations in prostate cancers treated with androgen antagonist by Taplin ME (1999)
  199. {'key': 'e_1_2_6_200_1', 'first-page': '663', 'article-title': 'GSTP1 CpG island DNA hypermethylation in hepatocellular carcinomas', 'volume': '16', 'author': 'Tchou JC', 'year': '2000', 'journal-title': 'Int J Oncol'} / Int J Oncol / GSTP1 CpG island DNA hypermethylation in hepatocellular carcinomas by Tchou JC (2000)
  200. {'key': 'e_1_2_6_201_1', 'first-page': '5221', 'article-title': 'MMAC1/PTEN mutations in primary tumor specimens and tumor cell lines', 'volume': '57', 'author': 'Teng DH', 'year': '1997', 'journal-title': 'Cancer Res'} / Cancer Res / MMAC1/PTEN mutations in primary tumor specimens and tumor cell lines by Teng DH (1997)
  201. 10.1056/NEJMoa030660
  202. {'key': 'e_1_2_6_203_1', 'first-page': '277', 'article-title': 'Mutations in the androgen receptor gene are associated with progression of human prostate cancer to androgen independence', 'volume': '2', 'author': 'Tilley WD', 'year': '1996', 'journal-title': 'Clin Cancer Res'} / Clin Cancer Res / Mutations in the androgen receptor gene are associated with progression of human prostate cancer to androgen independence by Tilley WD (1996)
  203. 10.1073/pnas.90.15.7181
  204. 10.1016/S0022-5347(05)68090-1
  205. 10.1016/S0021-9258(18)55395-3
  206. 10.1002/pros.10116
  207. 10.1002/ijc.2910480206
  208. 10.1038/labinvest.3780133
  209. 10.1016/S0002-9440(10)64286-1
  210. 10.1038/nature01075
  211. 10.1016/0167-4889(90)90075-O
  212. {'key': 'e_1_2_6_213_1', 'first-page': '6182', 'article-title': 'Colocalization of basal and luminal cell‐type cytokeratins in human prostate cancer', 'volume': '52', 'author': 'Verhagen AP', 'year': '1992', 'journal-title': 'Cancer Res'} / Cancer Res / Colocalization of basal and luminal cell‐type cytokeratins in human prostate cancer by Verhagen AP (1992)
  213. 10.1038/ng0495-401
  214. 10.1038/nrc839
  215. {'key': 'e_1_2_6_216_1', 'first-page': '4455', 'article-title': 'Coding region of NKX3.1, a prostate‐specific homeobox gene on 8p21, is not mutated in human prostate cancers', 'volume': '57', 'author': 'Voeller HJ', 'year': '1997', 'journal-title': 'Cancer Res'} / Cancer Res / Coding region of NKX3.1, a prostate‐specific homeobox gene on 8p21, is not mutated in human prostate cancers by Voeller HJ (1997)
  216. 10.1016/S0891-5849(99)00207-5
  217. 10.1038/sj.onc.1206227
  218. {'key': 'e_1_2_6_219_1', 'first-page': '4283', 'article-title': 'Identification of differentially expressed genes by serial analysis of gene expression in human prostate cancer', 'volume': '61', 'author': 'Waghray A', 'year': '2001', 'journal-title': 'Cancer Res'} / Cancer Res / Identification of differentially expressed genes by serial analysis of gene expression in human prostate cancer by Waghray A (2001)
  219. 10.1101/gr.9.12.1198
  220. {'key': 'e_1_2_6_221_1', 'first-page': '811', 'article-title': 'Homozygous deletion of the PTEN tumor suppressor gene in a subset of prostate adenocarcinomas', 'volume': '4', 'author': 'Wang SI', 'year': '1998', 'journal-title': 'Clin Cancer Res'} / Clin Cancer Res / Homozygous deletion of the PTEN tumor suppressor gene in a subset of prostate adenocarcinomas by Wang SI (1998)
  221. 10.1093/jnci/91.4.347
  222. {'key': 'e_1_2_6_223_1', 'first-page': '2203', 'article-title': 'E‐7869 (R‐flurbiprofen) inhibits progression of prostate cancer in the TRAMP mouse', 'volume': '60', 'author': 'Wechter WJ', 'year': '2000', 'journal-title': 'Cancer Res'} / Cancer Res / E‐7869 (R‐flurbiprofen) inhibits progression of prostate cancer in the TRAMP mouse by Wechter WJ (2000)
  223. 10.1097/01.MP.0000038460.95912.6E
  224. {'key': 'e_1_2_6_225_1', 'first-page': '5974', 'article-title': 'Analysis of gene expression identifies candidate markers and pharmacological targets in prostate cancer', 'volume': '61', 'author': 'Welsh JB', 'year': '2001', 'journal-title': 'Cancer Res'} / Cancer Res / Analysis of gene expression identifies candidate markers and pharmacological targets in prostate cancer by Welsh JB (2001)
  225. 10.1093/jnci/87.9.652
  226. 10.1002/pros.2990160206
  227. 10.1172/JCI1617
  228. 10.1073/pnas.94.13.6954
  229. {'key': 'e_1_2_6_230_1', 'first-page': '1677', 'article-title': 'Identification of differentially expressed genes in human prostate cancer using subtraction and microarray', 'volume': '60', 'author': 'Xu J', 'year': '2000', 'journal-title': 'Cancer Res'} / Cancer Res / Identification of differentially expressed genes in human prostate cancer using subtraction and microarray by Xu J (2000)
  230. 10.1038/ng994
  231. {'key': 'e_1_2_6_232_1', 'first-page': '2253', 'article-title': 'Associations between hOGG1 sequence variants and prostate cancer susceptibility', 'volume': '62', 'author': 'Xu J', 'year': '2002', 'journal-title': 'Cancer Res'} / Cancer Res / Associations between hOGG1 sequence variants and prostate cancer susceptibility by Xu J (2002)
  232. 10.1159/000071839
  233. 10.1016/S0022-5347(01)63776-5
  234. 10.1097/00000478-200207000-00011
  235. 10.1002/ijc.2910290602
  236. 10.1055/s-0037-1614129
  237. {'key': 'e_1_2_6_238_1', 'first-page': '1008', 'article-title': 'Disruption of androgen receptor function inhibits proliferation of androgen‐refractory prostate cancer cells', 'volume': '62', 'author': 'Zegarra‐Moro OL', 'year': '2002', 'journal-title': 'Cancer Res'} / Cancer Res / Disruption of androgen receptor function inhibits proliferation of androgen‐refractory prostate cancer cells by Zegarra‐Moro OL (2002)
  238. {'key': 'e_1_2_6_239_1', 'first-page': '8617', 'article-title': 'Cyclooxygenase‐2 is up‐regulated in proliferative inflammatory atrophy of the prostate, but not in prostate carcinoma', 'volume': '61', 'author': 'Zha S', 'year': '2001', 'journal-title': 'Cancer Res'} / Cancer Res / Cyclooxygenase‐2 is up‐regulated in proliferative inflammatory atrophy of the prostate, but not in prostate carcinoma by Zha S (2001)
  239. 10.1073/pnas.89.6.2399
  240. 10.1073/pnas.91.8.3147
  241. 10.1093/emboj/16.21.6355
  242. 10.1097/00000478-200306000-00007
  243. 10.1097/00000478-200303000-00010
Dates
Type When
Created 21 years, 7 months ago (Jan. 27, 2004, 6:30 a.m.)
Deposited 1 year, 10 months ago (Oct. 18, 2023, 6:22 a.m.)
Indexed 1 month, 2 weeks ago (July 13, 2025, 10:52 p.m.)
Issued 21 years, 8 months ago (Dec. 15, 2003)
Published 21 years, 8 months ago (Dec. 15, 2003)
Published Online 21 years, 8 months ago (Dec. 15, 2003)
Published Print 21 years, 6 months ago (Feb. 15, 2004)
Funders 0

None

@article{De_Marzo_2003, title={Pathological and molecular mechanisms of prostate carcinogenesis: Implications for diagnosis, detection, prevention, and treatment}, volume={91}, ISSN={1097-4644}, url={http://dx.doi.org/10.1002/jcb.10747}, DOI={10.1002/jcb.10747}, number={3}, journal={Journal of Cellular Biochemistry}, publisher={Wiley}, author={De Marzo, Angelo M. and DeWeese, Theodore L. and Platz, Elizabeth A. and Meeker, Alan K. and Nakayama, Masashi and Epstein, Jonathan I. and Isaacs, William B. and Nelson, William G.}, year={2003}, month=dec, pages={459–477} }